DE3750093D1 - Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten. - Google Patents

Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.

Info

Publication number
DE3750093D1
DE3750093D1 DE3750093T DE3750093T DE3750093D1 DE 3750093 D1 DE3750093 D1 DE 3750093D1 DE 3750093 T DE3750093 T DE 3750093T DE 3750093 T DE3750093 T DE 3750093T DE 3750093 D1 DE3750093 D1 DE 3750093D1
Authority
DE
Germany
Prior art keywords
dna
test
related diseases
susceptibility
determine susceptibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750093T
Other languages
English (en)
Other versions
DE3750093T2 (de
Inventor
Ronald W Pero
Daniel G Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Preventive Medical Institute New York Ny Us
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3750093D1 publication Critical patent/DE3750093D1/de
Application granted granted Critical
Publication of DE3750093T2 publication Critical patent/DE3750093T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3750093T 1986-01-17 1987-01-16 Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten. Expired - Fee Related DE3750093T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82020386A 1986-01-17 1986-01-17

Publications (2)

Publication Number Publication Date
DE3750093D1 true DE3750093D1 (de) 1994-07-28
DE3750093T2 DE3750093T2 (de) 1995-01-26

Family

ID=25230175

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750093T Expired - Fee Related DE3750093T2 (de) 1986-01-17 1987-01-16 Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.

Country Status (6)

Country Link
US (1) US5482833A (de)
EP (1) EP0229674B1 (de)
JP (1) JP2534631B2 (de)
AT (1) ATE107705T1 (de)
DE (1) DE3750093T2 (de)
ES (1) ES2056790T3 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5449605A (en) * 1988-10-14 1995-09-12 Georgetown University Method of detecting a predisposition to cancer by detecting a deletion polymorphism in the gene for human poly (ADP-ribose) polymerase
WO1996014565A1 (en) * 1994-10-27 1996-05-17 Oxigene, Inc. Method of testing immune competency
FR2731711B1 (fr) 1995-03-15 1997-06-06 Rech Investissements Sfri Soc Procede de detection qualitative et quantitative de lesions de l'adn
US6017706A (en) * 1997-05-07 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Process for identifying compounds which protect against the formation of fluorescent light induced DNA lesions and x-ray-induced lesions
US6640211B1 (en) * 1999-10-22 2003-10-28 First Genetic Trust Inc. Genetic profiling and banking system and method
US20030003454A1 (en) * 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US8043807B2 (en) 2001-03-23 2011-10-25 Yeda Research And Development Co. Ltd. Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
US20080274456A1 (en) * 2004-06-09 2008-11-06 Bruce Yankner Methods and Compositions for Modifying Gene Regulation and Dna Damage in Ageing
KR20080031266A (ko) * 2005-06-10 2008-04-08 바이파 사이언스 인코포레이티드 Ｐａｒｐ 조절제 및 암의 치료
NZ587586A (en) * 2005-07-18 2012-04-27 Bipar Sciences Inc Treatment of cancer
US8381164B2 (en) * 2006-03-28 2013-02-19 The Boeing Company Method and system of intelligent interactive graphics electrical plug map to analyze text and distances between electrical contacts and physical layout file builder
US20100279327A1 (en) * 2006-06-12 2010-11-04 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
CA2655257A1 (en) * 2006-06-12 2008-12-04 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
CA2662337A1 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
US8143447B2 (en) * 2006-09-05 2012-03-27 Bipar Sciences, Inc. Treatment of cancer
WO2009064444A2 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
WO2009064738A2 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
US20090149397A1 (en) * 2007-12-07 2009-06-11 Bipar Sciences Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585736A (en) * 1983-10-18 1986-04-29 The United States Of America As Represented By The United States Department Of Energy Flow cytometric measurement of total DNA and incorporated halodeoxyuridine

Also Published As

Publication number Publication date
US5482833A (en) 1996-01-09
ES2056790T3 (es) 1994-10-16
EP0229674A3 (en) 1989-08-16
ATE107705T1 (de) 1994-07-15
DE3750093T2 (de) 1995-01-26
JP2534631B2 (ja) 1996-09-18
EP0229674B1 (de) 1994-06-22
JPS62224300A (ja) 1987-10-02
EP0229674A2 (de) 1987-07-22

Similar Documents

Publication Publication Date Title
DE3750093D1 (de) Test zur Feststellung der Empfänglichkeit für DNS-assoziierte Krankheiten.
DE3688931D1 (de) Arabinonukleinsäure-Sonden für DNS/RNS-Bestimmungen.
DE3579099D1 (de) Dna-sonden mit verbindungsfragment und sondengruppe.
DE3689727D1 (de) Granulierungsverfahren für enzyme.
DE3484832D1 (de) Nachweis von bakterien mittels nukleinsaeuren-hybridisation, markierte sonden und testsatz dafuer.
IS3350A7 (is) Efnabætt næringarefni og aðferð til framleiðslu þess ( efnabætt með nucleosides og/eða nucleotides)
DE3583716D1 (de) Diagnostische testmethoden.
ES8703934A1 (es) Un metodo para detectar una secuencia de polinucleotidos
DE69835010D1 (de) Feststellung von endometriumkrebs
ATE140488T1 (de) Genetischer test für zytochrom-p450
IL71715A0 (en) Method,gene probes and test kit for detecting bacteria by nucleic acid hybridization
ATE92523T1 (de) Verfahren zur abtrennung und reinigung von sialyl-transferasen.
ATE497164T1 (de) Testverfahren zur messung der phosphorylierung
ATE111961T1 (de) Verfahren zur bestimmung von polymerase- aktivität.
DE3888689D1 (de) Substrate für enzymtests.
DE3650054D1 (de) Reagenzverteiler für ein analysesystem.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
ATE91508T1 (de) Reagenzsatz zur chemischen terminalen markierung von dns.
EP0304215A3 (de) Phosphorylierungsreagenz und Verfahren zu seiner Verwendung
DE3578454D1 (de) Klinisches analysesystem und verfahren.
DE3786181D1 (de) Dns-probe, spezifisch fuer das maennliche genom der wiederkaeuer, ihre herstellung und verwendung.
ES547038A0 (es) Procedimiento de preparar sondas biologicas y oligonucleoticos.
ES8607983A1 (es) Un metodo para producir una sonda de hibridacion de polinu- cleotidos
DE3889120D1 (de) Chromosomspezifische nukleinsäurensonde für familial polyposis coli.
DE3789612D1 (de) Analytisches Element für die Vermessung von enzymatischer Aktivität.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: PREVENTIVE MEDICAL INSTITUTE, NEW YORK, N.Y., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee